Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

February 2022; Volume 42,Issue 2

Reviews

  • You have access
    Leptomeningeal Metastases of the Spine: A Systematic Review
    PAOLO PALMISCIANO, NAVRAJ S. SAGOO, ABDURRAHMAN F. KHARBAT, YVES J. KENFACK, OTHMAN BIN ALAMER, GIANLUCA SCALIA, GIUSEPPE E. UMANA, SALAH G. AOUN and ALI S. HAIDER
    Anticancer Research February 2022, 42 (2) 619-628; DOI: https://doi.org/10.21873/anticanres.15519
  • You have access
    The Role of Surgery for Pancreatic Neuroendocrine Tumors
    IOANNIS A. ZIOGAS, ROBIN SCHMITZ, DIMITRIOS MORIS and CORY J. VATSAAS
    Anticancer Research February 2022, 42 (2) 629-639; DOI: https://doi.org/10.21873/anticanres.15520
  • You have access
    Methionine Restriction: Ready for Prime Time in the Cancer Clinic?
    JUN YAMAMOTO, QINGHONG HAN, MARK SIMON, DANIEL THOMAS and ROBERT M. HOFFMAN
    Anticancer Research February 2022, 42 (2) 641-644; DOI: https://doi.org/10.21873/anticanres.15521
  • You have access
    Challenges of Surgical Resection of Carotid Body Tumors - Multiple Feeding Arteries and Preoperative Embolization
    KIYOTO SHIGA, KATSUNORI KATAGIRI, AYA IKEDA, DAISUKE SAITO, SHIN-ICHI OIKAWA, KODAI TSUCHIDA, JUN MIYAGUCHI, TAKAHIRO KUSAKA and AKIO TAMURA
    Anticancer Research February 2022, 42 (2) 645-652; DOI: https://doi.org/10.21873/anticanres.15522
  • You have access
    A Systematic Review of Minimally Invasive Versus Open Radical Antegrade Modular Pancreatosplenectomy for Pancreatic Cancer
    KOSEI TAKAGI, YUZO UMEDA, RYUICHI YOSHIDA, TAKAHITO YAGI and TOSHIYOSHI FUJIWARA
    Anticancer Research February 2022, 42 (2) 653-660; DOI: https://doi.org/10.21873/anticanres.15523
  • You have access
    The Role of Community Pharmacists in Addressing Medication-related Issues for Breast Cancer Patients Receiving Adjuvant Endocrine Therapy
    KINAN MOKBEL and KEFAH MOKBEL
    Anticancer Research February 2022, 42 (2) 661-666; DOI: https://doi.org/10.21873/anticanres.15524
  • You have access
    SBRT in Localized Renal Carcinoma: A Review of the Literature
    CAROLINA DE LA PINTA, RAQUEL GARCÍA LATORRE and RAQUEL FUENTES
    Anticancer Research February 2022, 42 (2) 667-674; DOI: https://doi.org/10.21873/anticanres.15525
  • You have access
    Minimally Invasive Transcervical Esophagectomy With Mediastinal Lymphadenectomy for Cancer. A Comparison With Standardized Techniques
    SPYRIDON DAVAKIS, ALEXANDROS CHARALABOPOULOS, ELEANDROS KYROS, PANAGIOTIS SAKARELLOS, GERASIMOS TSOUROUFLIS, DIMITRIOS DIMITROULIS and NIKOLAOS NIKITEAS
    Anticancer Research February 2022, 42 (2) 675-680; DOI: https://doi.org/10.21873/anticanres.15526

Experimental Studies

  • You have access
    The A20/TNFAIP3-CDC20-CASP1 Axis Promotes Inflammation-mediated Metastatic Disease in Triple-negative Breast Cancer
    CHRISTINE SONG, AYSE TUBA KENDI, VAL J. LOWE and SEUNGBAEK LEE
    Anticancer Research February 2022, 42 (2) 681-695; DOI: https://doi.org/10.21873/anticanres.15527
  • You have access
    CHFR-Promoter-Methylation Status Is Predictive of Response to Irinotecan-based Systemic Chemotherapy in Advanced Colorectal Cancer
    TOSHIAKI HAGIWARA, KIICHI SUGIMOTO, HIROTAKA MOMOSE, TAKAHIRO IRIE, KUMPEI HONJO, YU OKAZAWA, MASAYA KAWAI, SHINGO KAWANO, SHINYA MUNAKATA, MAKOTO TAKAHASHI, YUTAKA KOJIMA, NOBUKO SERIZAWA, AKIHITO NAGAHARA, ROBERT M. HOFFMAN, MALCOLM V. BROCK and KAZUHIRO SAKAMOTO
    Anticancer Research February 2022, 42 (2) 697-707; DOI: https://doi.org/10.21873/anticanres.15528
  • You have access
    A Novel Molecular Target in EGFR-mutant Lung Cancer Treated With the Combination of Osimertinib and Pemetrexed
    NATSUKI TAKANO, MASAHIRO SEIKE, TEPPEI SUGANO, KUNIKO MATSUDA, KAKERU HISAKANE, AKIKO YOSHIKAWA, SHINJI NAKAMICHI, RINTARO NORO and AKIHIKO GEMMA
    Anticancer Research February 2022, 42 (2) 709-722; DOI: https://doi.org/10.21873/anticanres.15529
  • You have access
    Ko143 Reverses MDR in Glioblastoma via Deactivating P-Glycoprotein, Sensitizing a Resistant Phenotype to TMZ Treatment
    SAMUEL D. LUSTIG, SRAVAN K. KODALI, SHARON L. LONGO, SOMANATH KUNDU and MARIANO S. VIAPIANO
    Anticancer Research February 2022, 42 (2) 723-730; DOI: https://doi.org/10.21873/anticanres.15530
  • You have access
    Oral-recombinant Methioninase Converts an Osteosarcoma from Methotrexate-resistant to -sensitive in a Patient-derived Orthotopic-xenograft (PDOX) Mouse Model
    YUSUKE AOKI, YASUNORI TOME, QINGHONG HAN, JUN YAMAMOTO, KAZUYUKI HAMADA, NORIYUKI MASAKI, YUTARO KUBOTA, MICHAEL BOUVET, KOTARO NISHIDA and ROBERT M. HOFFMAN
    Anticancer Research February 2022, 42 (2) 731-737; DOI: https://doi.org/10.21873/anticanres.15531
  • You have access
    High Incidence of Lymph-node Metastasis in a Pancreatic-cancer Patient-derived Orthotopic Xenograft (PDOX) NOG-Mouse Model
    NORIHIKO SUGISAWA, KENTARO MIYAKE, TAKASHI HIGUCHI, HIROMICHI OSHIRO, JUN HO PARK, KEI KAWAGUCHI, MICHAEL BOUVET, MICHIAKI UNNO and ROBERT M. HOFFMAN
    Anticancer Research February 2022, 42 (2) 739-743; DOI: https://doi.org/10.21873/anticanres.15532
  • You have access
    Exosomal p38 Mitogen-activated Protein Kinase Promotes Tumour Repopulation in TP53-mutated Bile Duct Cancer Cells
    MAMI OSAWA, YASUNOBU MATSUDA, JUN SAKATA and TOSHIFUMI WAKAI
    Anticancer Research February 2022, 42 (2) 745-757; DOI: https://doi.org/10.21873/anticanres.15533
  • You have access
    One DNA Methylation Regulates CHIP Gene Expression of Human Breast Cancer and Predicts Recurrence
    TATSUYUKI GOHNO, TORU HANAMURA, MASAFUMI KUROSUMI, HIROYUKI TAKEI, YURI YAMAGUCHI and SHIN-ICHI HAYASHI
    Anticancer Research February 2022, 42 (2) 759-766; DOI: https://doi.org/10.21873/anticanres.15534
  • You have access
    The Natural Estrogen Receptor Beta Agonist Silibinin as a Promising Therapeutic Tool in Diffuse Large B-cell Lymphoma
    ELENA ORTONA, SILVIA L. LOCATELLI, MARIA TERESA PAGANO, BARBARA ASCIONE, GIUSEPPA CAREDDU, MARIA LUISA DUPUIS, MATTEO MARCONI, CARMELO CARLO-STELLA, WALTER MALORNI, PAOLA MATARRESE and MARINA PIERDOMINICI
    Anticancer Research February 2022, 42 (2) 767-779; DOI: https://doi.org/10.21873/anticanres.15535
  • You have access
    Inhibition of Neurotoxicity/Anticancer Activity of Bortezomib by Caffeic Acid and Chlorogenic Acid
    REONA MATSUDA, HIROSHI SAKAGAMI, SHIGERU AMANO, YOSUKE IIJIMA, MOTOHIKO SANO, YOSHIHIRO UESAWA, NOBUAKI TAMURA, YOHEI OISHI and HIROSHI TAKESHIMA
    Anticancer Research February 2022, 42 (2) 781-790; DOI: https://doi.org/10.21873/anticanres.15536
  • You have access
    CRMP4 Up-regulates M2 Macrophages and Myeloid-derived Suppressor Cells to Promote Pancreatic Cancer in Mice
    YUZO MINEGISHI, YUKIHIKO HIROSHIMA, KEIICHI YAZAWA, SHO SATO, YASUHIRO YABUSHITA, YUKI HOMMA, RYUSEI MATSUYAMA, IKUMA KATO, YOSHIO GOSHIMA and ITARU ENDO
    Anticancer Research February 2022, 42 (2) 791-799; DOI: https://doi.org/10.21873/anticanres.15537
  • You have access
    Therapeutic Response Evaluation in Advanced Melanoma Patients Incorporating Plasma cfDNA, LDH, VEGF, PD-L1, and IFN-γ Measurements
    MICHAEL I. ITA, JIANG H. WANG, CYNTHIA C. HEFFRON, DEREK G. POWER, YVONNE NOLAN, ANDRÉ TOULOUSE, CHRIS C.H. LIM, NOEL FANNING and HENRY P. REDMOND
    Anticancer Research February 2022, 42 (2) 801-810; DOI: https://doi.org/10.21873/anticanres.15538
  • You have access
    Micro-RNA378a-3p Induces Apoptosis in Sarcomatoid Renal Cell Carcinoma and Regulates POLR2A and RUNX2 Expression
    WEN-HUI WENG, KAI-JIE YU, JU-WEN JHAN, SWO-NENG PANG, YUEH-ER CHIOU and SEE-TONG PANG
    Anticancer Research February 2022, 42 (2) 811-825; DOI: https://doi.org/10.21873/anticanres.15539
  • You have access
    A Novel Injectable Hydrogel Matrix Loaded With 90Y Microspheres for the Treatment of Solid Tumors
    ANTONINO AMATO, PIER LUIGI CARRIERO, GORDON MCVIE and GIOVANNI PAGANELLI
    Anticancer Research February 2022, 42 (2) 827-836; DOI: https://doi.org/10.21873/anticanres.15540
  • You have access
    Effect of Thymidine Phosphorylase Gene Demethylation on Sensitivity to 5-Fluorouracil in Colorectal Cancer Cells
    MUNEYUKI KOYAMA, ERIKA OSADA, NUBUTAKE AKIYAMA, KEN ETO and YOSHINOBU MANOME
    Anticancer Research February 2022, 42 (2) 837-844; DOI: https://doi.org/10.21873/anticanres.15541
  • You have access
    Snail Mucus Enhances Chemosensitivity of Triple-negative Breast Cancer Via Activation of the Fas Pathway
    CHIEN-YI HO, DAI-WEI HU, BO-RONG CHEN, CHUN-CHUN YANG, CHUN-HSU YAO, TIEN NI, WEI-CHUAN HO, YUEH-SHENG CHEN, CHIH-YEN TU, WEI-CHAO CHANG, YANG-CHANG WU, CHIH-HSIN TANG, HUI-CHI HUANG, WEI-CHIEN HUANG and TZONG-SHIUN LI
    Anticancer Research February 2022, 42 (2) 845-855; DOI: https://doi.org/10.21873/anticanres.15542
  • You have access
    Inhibitory Effect of Oxaliplatin-loaded Engineered Milk Extracellular Vesicles on Tumor Progression
    GYEONGYUN GO, HEE JUNG PARK, JUN HEE LEE, CHUL WON YUN and SANG HUN LEE
    Anticancer Research February 2022, 42 (2) 857-866; DOI: https://doi.org/10.21873/anticanres.15543
  • You have access
    Enhancement of Radiation Response Associated With Metformin in Hepatocellular Carcinoma: Preclinical Animal and Clinical Cohort Study
    WON IL JANG, MI-SOOK KIM, JAE-HOON JEONG, WONWOO KIM and JAE SUNG KIM
    Anticancer Research February 2022, 42 (2) 867-876; DOI: https://doi.org/10.21873/anticanres.15544
  • You have access
    Patterns of Tumor Vasculogenesis on a Chick Embryo Chorioallantoic Membrane In Vivo Model of Breast Cancer
    SERBAN COMSA, AMALIA-RALUCA CEAUSU, ROXANA POPESCU, ANCA-MARIA CIMPEAN, SIMONA SARB and MARIUS RAICA
    Anticancer Research February 2022, 42 (2) 877-883; DOI: https://doi.org/10.21873/anticanres.15545
  • You have access
    BAX But Not BCL2 Is Necessary for Apoptosis in Neuroblastoma Cells Treated With Casiopeína® IIIia
    LUIS ARTURO JAIME-MARTINEZ, MONICA L. MARTINEZ-PACHECO, LENA RUIZ-AZUARA and CARMEN MEJIA
    Anticancer Research February 2022, 42 (2) 885-892; DOI: https://doi.org/10.21873/anticanres.15546

Clinical Studies

  • You have access
    Postoperative Treatment of Resectable Pancreatic Cancer With Positive Peritoneal Lavage Cytology: A Multicentre Retrospective Study
    AKIKO TODAKA, SATOSHI NARA, FUYUHIKO MOTOI, SOICHIRO MORINAGA, REISHI TOSHIYAMA, RYOTA HIGUCHI, MASARU KONISHI, HIROFUMI SHIRAKAWA, HIDETAKA TSUMURA, HIROYUKI OKUYAMA, HIROAKI NAGANO, KAZUHIKO SHIOJI, KEISHI SUGIMACHI, AKINORI ASAGI, NOBUMASA MIZUNO and JUNJI FURUSE
    Anticancer Research February 2022, 42 (2) 893-902; DOI: https://doi.org/10.21873/anticanres.15547
  • You have access
    Feasibility and Safety of Laparoscopic Gallbladder Resection for Gallbladder Tumours
    HAJIME IMAMURA, TOMOHIKO ADACHI, TAKAYUKI TANAKA, HAJIME MATSUSHIMA, TAKANOBU HARA, AKIHIKO SOYAMA, MASAAKI HIDAKA and SUSUMU EGUCHI
    Anticancer Research February 2022, 42 (2) 903-910; DOI: https://doi.org/10.21873/anticanres.15548
  • You have access
    Peritumoral Hyperintensity at Hepatobiliary Phase Gadoxetic Acid–enhanced MRI in Hepatic Neuroendocrine Tumors
    NOBUHIRO FUJITA, ATSUHIKO HANDA and JINHA M. PARK
    Anticancer Research February 2022, 42 (2) 911-917; DOI: https://doi.org/10.21873/anticanres.15549
  • You have access
    Outcomes of Intramedullary Nail Fixation for Metastatic Disease: Impending and Pathologic Fractures
    AARON R. OWEN, MASON E. UVODICH, VIVEK SOMASUNDARAM, BRANDON J. YUAN, PETER S. ROSE and MATTHEW T. HOUDEK
    Anticancer Research February 2022, 42 (2) 919-922; DOI: https://doi.org/10.21873/anticanres.15550
  • You have access
    Implementation of Locoregional Adjuvant Radiotherapy for Breast Cancer in a Rural Healthcare Region: Toxicity Outcomes in the Initial Cohort
    CARSTEN NIEDER, JOAKIM RESSHEIM, ELLINOR C. HAUKLAND and BÅRD MANNSÅKER
    Anticancer Research February 2022, 42 (2) 923-928; DOI: https://doi.org/10.21873/anticanres.15551
  • You have access
    Sacral Chordoma: A Population-based Analysis of Epidemiology and Survival Outcomes
    MATTEO SCAMPA, ENRICO TESSITORE, DENNIS E. DOMINGUEZ, DIDIER HANNOUCHE, NICOLAS C. BUCHS, DANIEL F. KALBERMATTEN and CARLO M. ORANGES
    Anticancer Research February 2022, 42 (2) 929-937; DOI: https://doi.org/10.21873/anticanres.15552
  • You have access
    Utility of Follow-up With Absolute Lymphocyte Count in Patients Undergoing Eribulin Treatment for Early Detection of Progressive Advanced or Metastatic Breast Cancer
    WATARU GOTO, SHINICHIRO KASHIWAGI, KOJI TAKADA, YUKA ASANO, TAMAMI MORISAKI, MASATSUNE SHIBUTANI, HIROAKI TANAKA, KOSEI HIRAKAWA and MASAICHI OHIRA
    Anticancer Research February 2022, 42 (2) 939-946; DOI: https://doi.org/10.21873/anticanres.15553
  • You have access
    Computed Tomography-assessed Skeletal Muscle Index and Skeletal Muscle Radiation Attenuation in Patients With Ovarian Cancer Treated With Primary Surgery Followed by Platinum-based Chemotherapy: A Single-center Italian Study
    ANGIOLO GADDUCCI, ENRICO SIMONETTI, FRANCESCO MEZZAPESA, STEFANIA COSIO, MARIO MICCOLI, JESSICA FREY, RACHELE TINTORI, ALESSANDRA BULLERI and EMANUELE NERI
    Anticancer Research February 2022, 42 (2) 947-954; DOI: https://doi.org/10.21873/anticanres.15554
  • You have access
    Hope as a Lifeline: Imatinib Discontinuation in Patients With Oligometastatic Gastrointestinal Stromal Tumours
    LENA FAUSKE, PERNILLE H. WÆRSTAD, IVAR HOMPLAND and ØYVIND S. BRULAND
    Anticancer Research February 2022, 42 (2) 955-963; DOI: https://doi.org/10.21873/anticanres.15555
  • You have access
    Circulating Markers of Neutrophil Extracellular Traps (NETs) in Patients With Ovarian Tumors
    ARTURAS DOBILAS, CHARLOTTE THALIN, HAKAN WALLEN and CHRISTER BORGFELDT
    Anticancer Research February 2022, 42 (2) 965-971; DOI: https://doi.org/10.21873/anticanres.15556
  • You have access
    Comparative Efficacy of Combination Therapy of Ipilimumab Plus Nivolumab for Non-clear Cell Renal Cell Carcinoma
    YUKARI BANDO, JUNYA FURUKAWA, YASUYOSHI OKAMURA, TAKUTO HARA, TOMOAKI TERAKAWA, YUZO NAKANO and MASATO FUJISAWA
    Anticancer Research February 2022, 42 (2) 973-979; DOI: https://doi.org/10.21873/anticanres.15557
  • You have access
    Treatment Efficacy of PD-1 Inhibitor Therapy in Patients With Recurrent and/or Metastatic Salivary Gland Carcinoma
    KAZUKI HASHIMOTO, RYUJI YASUMATSU, RYOSUKE KUGA, TAKAHIRO HONGO, HIDETAKA YAMAMOTO, MIOKO MATSUO, TAKAHIRO WAKASAKI, RINA JIROMARU, TOMOMI MANAKO, SATOSHI TOH, MUNEYUKI MASUDA, MORIYASU YAMAUCHI, YUICHIRO KURATOMI, HIDEOKI URYU, TORAHIKO NAKASHIMA, AKIHIRO TAMAE, RISA TANAKA, MASAHIKO TAURA, TORANOSHIN TAKEUCHI, TAKAMASA YOSHIDA and TAKASHI NAKAGAWA
    Anticancer Research February 2022, 42 (2) 981-989; DOI: https://doi.org/10.21873/anticanres.15558
  • You have access
    Intensified Total Neoadjuvant Therapy Versus Intensified Concurrent Chemoradiotherapy in Locally Advanced Rectal Cancer: A Propensity Score Matching Analysis
    FRANCESCA DE FELICE, DANIELA MUSIO, FRANCO IAFRATE, SALVATORE CAPONNETTO, VINCENZO PICONE, GIANCARLO D’AMBROSIO, FABIO MASSIMO MAGLIOCCA, FRANCESCA TOZZI, GIORGIO DE TOMA, VINCENZO TOMBOLINI and ENRICO CORTESI
    Anticancer Research February 2022, 42 (2) 991-1000; DOI: https://doi.org/10.21873/anticanres.15559
  • You have access
    Second-look Surgery Detects Low Volume Recurrent Disease Following Cytoreductive Surgery for Peritoneal Carcinomatosis
    AMER MATAR, KHALED ALTOUKHI, ANDREW TSE, JENNY SOHN, NAYEF ALZAHRANI and DAVID L. MORRIS
    Anticancer Research February 2022, 42 (2) 1001-1006; DOI: https://doi.org/10.21873/anticanres.15560
  • You have access
    Efficacy of Ring Drape and Unused Sterile Instruments for Incisional SSI After Hepatectomy
    TOSHIHIKO YUSA, YO-ICHI YAMASHITA, HIDETOSHI NITTA, YOSUKE NAKAO, RUMI ITOYAMA, YUKI KITANO, TAKAYOSHI KAIDA, TATSUNORI MIYATA, KOSUKE MIMA, KATSUNORI IMAI, HIROMITSU HAYASHI and HIDEO BABA
    Anticancer Research February 2022, 42 (2) 1007-1012; DOI: https://doi.org/10.21873/anticanres.15561
  • You have access
    Pre-pectoral Immediate Breast Reconstruction Following Conservative Mastectomy Using Acellular Dermal Matrix and Semi-smooth Implants
    UMAR WAZIR, NEILL PATANI, JENNIFER HEENEY, KINAN MOKBEL and KEFAH MOKBEL
    Anticancer Research February 2022, 42 (2) 1013-1018; DOI: https://doi.org/10.21873/anticanres.15562
  • You have access
    Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Doxorubicin for 90 Minutes Versus 60 Minutes After Cytoreductive Surgery (CRS). Does the 30-Minute Difference Matter? A Comparative Study in a High Volume Centre
    MIKLOS ACS, LASZLO HALMY, SABINA ISGANDAROVA, SEBASTIAN BLAJ, MICHAEL GERKEN, BERNHARD HORMANN and POMPILIU PISO
    Anticancer Research February 2022, 42 (2) 1019-1029; DOI: https://doi.org/10.21873/anticanres.15563
  • You have access
    Safety and Efficacy of RAD001 (Everolimus) Administered Upon Relapse During or After Adjuvant Treatment in Post-menopausal Women With Hormone Receptor Positive, HER2/neu Negative Locally Advanced or Metastatic Breast Cancer (CRAD001JGR08 “MELPOMENI” study)
    ATHANASIOS ALEXOPOULOS, CHARISIOS KARANIKIOTIS, ALEXANDROS ARDAVANIS, IOANNIS BOUKOVINAS, PARISIOS MAKRANTONAKIS, CHRISTOS PAPADIMITRIOU, ATHANASIOS ATHANASIADIS, ANASTASIOS BOUTIS, STYLIANOS GIASSAS, STYLIANOS KAKOLYRIS, GEORGIOS KOUMAKIS, KONSTANTINOS PAPAZISIS, ADAMANTIA PSYRRI, NIKOLAOS ZIRAS, SOFIA BAKA, NIKOLAOS KENTEPOZIDIS and VASILIKI MICHALAKI
    Anticancer Research February 2022, 42 (2) 1031-1041; DOI: https://doi.org/10.21873/anticanres.15564
  • You have access
    Risk Factors for Hepatic Toxicity of High-dose Methotrexate in Patients With Osteosarcoma
    KENTARO ABE, AYAKO MAEDA-MINAMI, TAKU ISHIZU, SHINTARO IWATA, EISUKE KOBAYASHI, TATSUNORI SHIMOI, YOHEI KAWANO, HIRONOBU HASHIMOTO, MASAKAZU YAMAGUCHI, TETSUYA FURUKAWA, SATORU MIYAZAKI and YASUNARI MANO
    Anticancer Research February 2022, 42 (2) 1043-1050; DOI: https://doi.org/10.21873/anticanres.15565
  • You have access
    Prognostic and Clinicopathological Significance of Lymph Node Metastasis in the Esophagogastric Junction Adenocarcinoma
    NAOKI URAKAWA, SHINGO KANAJI, SATOSHI SUZUKI, RYUICHIRO SAWADA, HITOSHI HARADA, HIRONOBU GOTO, HIROSHI HASEGAWA, KIMIHIRO YAMASHITA, TAKERU MATSUDA, TARO OSHIKIRI and YOSHIHIRO KAKEJI
    Anticancer Research February 2022, 42 (2) 1051-1057; DOI: https://doi.org/10.21873/anticanres.15566
  • You have access
    Spontaneous Chromosomal Aberrations in Lymphocytes and Development of Tumor in Hospital Workers
    GYÖNGYI FARKAS, ZSUZSA S. KOCSIS, GÁBOR SZÉKELY, ISTVÁN KENESSEY, CSABA POLGÁR and ZSOLT JURÁNYI
    Anticancer Research February 2022, 42 (2) 1059-1064; DOI: https://doi.org/10.21873/anticanres.15567
  • You have access
    Ra-223 and Ethinylestradiol Combination Therapy in Castration-resistant Prostate Cancer
    TAKAFUMI SHIMADA, KOUJI IZUMI, HIROSHI KANO, SUGURU KADOMOTO, TOMOYUKI MAKINO, RENATO NAITO, HIROAKI IWAMOTO, HIROSHI YAEGASHI, YOSHIFUMI KADONO and ATSUSHI MIZOKAMI
    Anticancer Research February 2022, 42 (2) 1065-1071; DOI: https://doi.org/10.21873/anticanres.15568
  • You have access
    Differences in the Therapeutic Effect of Chemotherapy Regimens for Concurrent Chemoradiotherapy of Locally Advanced Non-small Cell Lung Cancer
    MINORU HORIUCHI, TETSUYA OGURI, YUSUKE KAGAWA, KAZUKI SONE, SATOSHI FUKUDA, TAKEHIRO UEMURA, OSAMU TAKAKUWA, KEN MAENO, KENNSUKE FUKUMITSU, YOSHIHIRO KANEMITSU, TOMOKO TAJIRI, HIROTSUGU OHKUBO, MASAYA TAKEMURA, YUTAKA ITO and AKIO NIIMI
    Anticancer Research February 2022, 42 (2) 1073-1079; DOI: https://doi.org/10.21873/anticanres.15569
  • You have access
    Pretreatment Neutrophil Count and Platelet-lymphocyte Ratio as Predictors of Metastasis in Patients With Osteosarcoma
    YOSHIHIRO ARAKI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, AKIHIKO TAKEUCHI, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, KENSAKU ABE, YUTA TANIGUCHI, HIROTAKA YONEZAWA, SEI MORINAGA, YOHEI ASANO and HIROYUKI TSUCHIYA
    Anticancer Research February 2022, 42 (2) 1081-1089; DOI: https://doi.org/10.21873/anticanres.15570
  • You have access
    Investigation of Hypersensitivity Reactions in Carboplatin Desensitization Therapy
    NAOKI SHIBATA, KAZUYOSHI KAWAKAMI, SHIMIZU HISANORI, KAZUO KOBAYASHI, MAYU YUNOKAWA, HIROYUKI KANAO, IORI TAKI, REMI MURASE, DAISUKE KAMEI and MASAKAZU YAMAGUCHI
    Anticancer Research February 2022, 42 (2) 1091-1097; DOI: https://doi.org/10.21873/anticanres.15571
  • You have access
    Subsequent-abemaciclib Treatment After Disease Progression on Palbociclib in Patients With ER-positive HER2-negative Metastatic Breast Cancer
    HIROHITO SEKI, TAKASHI SAKURAI, AKIHISA SAKURADA, TETSUHIKO KINOSHITA and KEN SHIMIZU
    Anticancer Research February 2022, 42 (2) 1099-1106; DOI: https://doi.org/10.21873/anticanres.15572
  • You have access
    Prognostic Significance of 3-Month Prostate-specific Antigen Level Following Androgen-deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer
    YUJIRO NAGATA, TAKUO MATSUKAWA, IKKO TOMISAKI and NAOHIRO FUJIMOTO
    Anticancer Research February 2022, 42 (2) 1107-1114; DOI: https://doi.org/10.21873/anticanres.15573
  • You have access
    Increased Transumbilical Incision Complication Rates With Laparoscopic Colorectal Resection: A Single-center Propensity Score-matched Cohort Study
    KODAI TOMIOKA, TAKESHI AOKI, MAKOTO WATANABE, YUTA ENAMI, AKIRA FUJIMORI, TOMOTAKE KOIZUMI, SATORU GOTO, KIMIYASU YAMAZAKI, KOJI OTSUKA and MASAHIKO MURAKAMI
    Anticancer Research February 2022, 42 (2) 1115-1121; DOI: https://doi.org/10.21873/anticanres.15574
  • You have access
    Risk and Protective Factors for Postoperative Complications in Elderly Patients With Colorectal Cancer
    TAKUYA SHIRAISHI, HIROOMI OGAWA, NAOYA OZAWA, KUNIHIKO SUGA, CHIKA KOMINE, YUTA SHIBASAKI, KATSUYA OSONE, TAKUHISA OKADA, YASUAKI ENOKIDA, MAKOTO SOHDA, KEN SHIRABE and HIROSHI SAEKI
    Anticancer Research February 2022, 42 (2) 1123-1130; DOI: https://doi.org/10.21873/anticanres.15575
  • You have access
    Platelet-to-Lymphocyte Ratio Predicts the Efficacy of Pembrolizumab in Patients With Urothelial Carcinoma
    RYO KURASHINA, KIYOHIRO ANDO, MASAHARU INOUE, KEITA IZUMI, RIKO MARUYAMA, KOUKI MITANI, HISANORI TAKENOBU, MASAYUKI HARUTA, TOSHIHIKO IIZUKA, TAKEHIKO KAMIJO and YUKIO KAGEYAMA
    Anticancer Research February 2022, 42 (2) 1131-1136; DOI: https://doi.org/10.21873/anticanres.15576
  • You have access
    Consideration of the Optimal Surgical Procedure Based on the Risk of Recurrence in Clinical Stage 0 or IA Lung Adenocarcinoma
    TOMOYOSHI TAKENAKA, TETSUZO TAGAWA, MIKIHIRO KOHNO, NAOKI HARATAKE, FUMIHIKO KINOSHITA, YUKI ONO, SHO WAKASU, YUKA OKU and MASAKI MORI
    Anticancer Research February 2022, 42 (2) 1137-1142; DOI: https://doi.org/10.21873/anticanres.15577
  • You have access
    High vs. Standard Radiotherapy Dose in Locally Advanced Rectal Adenocarcinoma Patients Treated With Neoadjuvant Long Course Chemoradiotherapy: A Population-based Study
    JI-AN LIANG, YU-CHENG KUO, K.S. CLIFFORD CHAO, WILLIAM TZU-LIANG CHEN, TAO-WEI KE, SZU-HSIEN CHOU, CHIA-CHIN LI and CHUN-RU CHIEN
    Anticancer Research February 2022, 42 (2) 1143-1150; DOI: https://doi.org/10.21873/anticanres.15578
  • You have access
    Awake Surgery for Local Recurrence of Brain Metastasis in the Precentral Gyrus After Fractionated Stereotactic Radiotherapy: A Technical Case Report
    RYOSUKE MATSUDA, FUMIYA SATO, MASASHI KOTSUGI, TAKAYUKI MORIMOTO, FUMIHIKO NISHIMURA, ICHIRO NAKAGAWA and HIROYUKI NAKASE
    Anticancer Research February 2022, 42 (2) 1151-1155; DOI: https://doi.org/10.21873/anticanres.15579
  • You have access
    Bilateral Lung Transplant for Treatment of Idiopathic Pulmonary Fibrosis With Undetected Lung Adenocarcinoma: A Case Report
    UZAIR M. JOGIAT, QUINCY S. CHU, JAYAN NAGENDRAN, BRYCE LAING, ALIM HIRJI and BENJAMIN A. ADAM
    Anticancer Research February 2022, 42 (2) 1157-1160; DOI: https://doi.org/10.21873/anticanres.15580
  • You have access
    Efficacy and Safety of Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Living Donor Liver Transplantation: A Report of Two Cases
    AKIHIKO ICHIDA, NOBUHISA AKAMATSU, RIHITO NAGATA, YUICHIRO MIHARA, YOSHIKUNI KAWAGUCHI, SUNG KWAN BAE, TAKEAKI ISHIZAWA, JUNICHI KANEKO, JUNICHI ARITA and KIYOSHI HASEGAWA
    Anticancer Research February 2022, 42 (2) 1161-1167; DOI: https://doi.org/10.21873/anticanres.15581
  • You have access
    A Rare Case of Brain Metastasis of Thymic Carcinoma
    TAKAAKI MITSUI, RYOSUKE MATSUDA, KAZUO GODA, HIROE ITAMI, ICHIRO NAKAGAWA and HIROYUKI NAKASE
    Anticancer Research February 2022, 42 (2) 1169-1174; DOI: https://doi.org/10.21873/anticanres.15582
  • You have access
    Stratified Mucin-producing Intraepithelial Lesions of the Cervix: Clinical Diversity of Cases and Literature Review
    CHARLOTTE DELRUE, LIEVE VANWALLEGHEM, PASCALE DE PAEPE and PHILIPPE VAN TRAPPEN
    Anticancer Research February 2022, 42 (2) 1175-1180; DOI: https://doi.org/10.21873/anticanres.15583
  • You have access
    Republication: A Prospective Observational Study of Adoptive Immunotherapy for Cancer Using Zoledronate-Activated Killer (ZAK) Cells – An Analysis for Patients With Incurable Pancreatic Cancer
    YOSHIYUKI YAMAGUCHI, YOUSUKE KATATA, MAKOTO OKAWAKI, AKIRA SAWAKI and MASAHIRO YAMAMURA
    Anticancer Research February 2022, 42 (2) 1181-1187; DOI: https://doi.org/10.21873/anticanres.15584
Back to top
PreviousNext

In this issue

Anticancer Research: 42 (2)
Anticancer Research
Vol. 42, Issue 2
February 2022
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • CHFR-Promoter-Methylation Status Is Predictive of Response to Irinotecan-based Systemic Chemotherapy in Advanced Colorectal Cancer
  • A Novel Molecular Target in EGFR-mutant Lung Cancer Treated With the Combination of Osimertinib and Pemetrexed
  • Ko143 Reverses MDR in Glioblastoma via Deactivating P-Glycoprotein, Sensitizing a Resistant Phenotype to TMZ Treatment
  • The Natural Estrogen Receptor Beta Agonist Silibinin as a Promising Therapeutic Tool in Diffuse Large B-cell Lymphoma
  • The A20/TNFAIP3-CDC20-CASP1 Axis Promotes Inflammation-mediated Metastatic Disease in Triple-negative Breast Cancer
Sign up for alerts

Jump to

  • Reviews
  • Experimental Studies
  • Clinical Studies
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire